Treatment outcomes of patients with AJCC stage IVC nasopharyngeal carcinoma: Benefits of primary radiotherapy

Japanese Journal of Clinical Oncology

Volumn 36, Issue 3, 2006, Pages 132-136

  Yeh, Shyh An ^a,b   Tang, Yeh ^a   Lui, Chun Chung ^a   Huang, Eng Yen ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b NONE   (Taiwan)

Author keywords

Chemotherapy; Metastasis; Nasopharyngeal carcinoma; Radiotherapy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGE; AGED; ARTICLE; BONE MARROW SUPPRESSION; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; CHEMOTHERAPY INDUCED EMESIS; COMPARATIVE STUDY; CONTROLLED STUDY; DYSPHAGIA; FEMALE; FIBROSIS; HEARING IMPAIRMENT; HISTOPATHOLOGY; HOARSENESS; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METASTASIS; MUCOSA INFLAMMATION; MULTIVARIATE ANALYSIS; NASOPHARYNX CARCINOMA; NAUSEA; PROGNOSIS; QUALITY OF LIFE; SURVIVAL RATE; TINNITUS; TREATMENT OUTCOME; TRISMUS; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; CISPLATIN; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33645841940     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyi245     Document Type: Article

References (33)

1. Al-Kourainy K, Crissman J, Ensley J, Kish J, Kelly J, Al-Sarraf M. Excellent response to cis-platinum-based chemotherapy in patients with recurrent or previously untreated advanced nasopharyngeal carcinoma. Am J Clin Oncol 1988;11:427-30.
2. Chan AT, Teo PM, Leung TW, Johnson PJ. The role of chemotherapy in the management of nasopharyngeal carcinoma. Cancer 1998;82:1003-12.
3. Fu KK. Combined radiotherapy and chemotherapy for nasopharyngeal carcinoma. Semin Radiat Oncol 1998;8:247-53.
4. Lin JC, Jan JS, Hsu CY. Pilot study of concurrent chemotherapy and radiotherapy for stage IV nasopharyngeal cancer. Am J Clin Oncol 1997;20:6-10.
5. Ali H, Al-Sarraf M. Chemotherapy in advanced nasopharyngeal carcinoma. Oncology 2000;14:1223-30.
6. Chen WZ, Zhou DL, Luo KS. Long-term observation after radiotherapy for nasopharyngeal carcinoma (NPC). Int J Radiat Oncol Biol Phys 1989;16:311-14.
7. Fandi A, Altrun M, Azli N, Armand JP, Cvitkovic E. Nasopharyngeal carcinoma: Epidemiology, staging, and treatment. Semin Oncol 1994;21:382-97.
8. Frezza G, Barbieri E, Emiliani E, Silvano M, Babini L. Patterns of failure in nasopharyngeal cancer treated with megavoltage irradiation. Radiother Oncol 1986;5:287-94.
9. Ho JHC. An epidemiologic and clinical study of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1978;4:183-98.
10. Huang SC. Nasopharyngeal cancer: A review of 1605 patients treated radically with cobalt 60. Int J Radiat Oncol Biol Phys 1980;6:401-7.
11. Vikram B, Mishra UB, Strong EW, Manolatos S. Patterns of failure in carcinoma of the nasopharynx: Failure at distant sites. Head Neck Surg 1986;8:276-9.
12. Zhang EP, Lian PG, Cai KL, Chen YF, Cai MD, Zheng XF, et al. Radiation therapy of nasopharyngeal carcinoma: Prognostic factors based on a 10-year follow-up of 1302 patients. Int J Radiat Oncol Biol Phys 1989;16:301-5.
13. Fleming ID, Cooper JS, Henson DE, et al. American Joint Committee on Cancer. Manual for Staging of Cancer. 5th edn. Philadelphia, PA: Lippincott-Raven 1997.
14. International Histological Classification of Tumors. Histological Typing of Upper Respiratory Tract Tumors. World Health Organization 1978;19:32-33.
15. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995;31:1341-6.
16. Pavy JJ, Denekamp J, Letschert J, Littbrand B, Mornex F, Bernier J, et al. Late effects toxicity scoring: The SOMA scale. Int J Radiat Oncol Biol Phys 1995;31:1043-91.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
18. Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 1977;35:1-39.
19. Cox DR. Regression models and life tables. J Royal Stat Soc 1972;34:187-220.
20. Teo PM, Kwan WH, Lee WY, Leung SF, Johnson PJ. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 1996;77:2423-31.
21. Neel HB, Taylor WF, Pearson GR. Prognostic determinants and a new view of staging for patients with nasopharyngeal carcinoma. Ann Otol Rhinol Laryngol 1985;94:529-37.
22. Grandi C, Boracchi P, Mezzanotte G, Squadrelli M, Marubini E, Molinari R. Analysis of prognostic factors and proposal of a new classification for nasopharyngeal cancer. Head Neck 1990;12:31-40.
23. Sham JS, Choy D. Prognostic factors of nasopharyngeal carcinoma: A review of 759 patients. Brit J Radiol 1990;63:51-8.
24. Dickson RI, Flores AD. Nasopharyngeal carcinoma: An evaluation of 134 patients treated between 1971 and 1980. Laryngoscope 1985;95:276-83.
25. Bailet JW, Mark RJ, Abemayor E, Lee SP, Tran LM, Julliard G, et al. Nasopharyngeal carcinoma: Treatment results with primary radiation therapy. Laryngoscope 1992;102:965-72.
26. Perez CA, Devineni VR, Marcial-Vega V, Marks JE, Simpson JR, Kucik N. Carcinoma of the nasopharynx: Factors affecting prognosis. Int J Radiat Oncol Biol Phys 1992;23:271-80.
27. Erkal HS, Serin M, Cakmak A. Nasopharyngeal carcinomas: Analysis of patient, tumor and treatment characteristics determining outcome. Radiother Oncol 2001;61:247-56.
28. Choo R, Tannock I. Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx. Cancer 1991;68:2120-4.
29. Decker DA, Drelichman A, Al-Sarraf M, Crissman J, Reed ML. Chemotherapy for nasopharyngeal carcinoma: A ten-year experience. Cancer 1983;52:602-5.
30. Stein ME, Ruff P, Weaving A, Fried J, Bezwoda WR. A phase II study of cisplatin/ifosfamide in recurrent/metastatic undifferentiated nasopharyngeal carcinoma among young blacks in southern Africa. Am J Clin Oncol 1996;19:386-8.
31. Yeo W, Leung TW, Chan AT, Chiu SK, Yu P, Mok TS, et al. A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma. Eur J Cancer 1998;34:2027-31.
32. Fountzilas G, Skarlos D, Athanassiades A, Kalogera-Fountzila A, Samantas E, Bacoyiannis C, et al. Paclitaxel by three-hour infusion and carboplatin in advanced carcinoma of nasopharynx and other sites of the head and neck: A phase II study conducted by the Hellenic Cooperative Oncology Group. Ann Oncol 1997;8:451-5.
33. Tan EH, Khoo KS, Wee J, Fong KW, Lee KS, Lee KM, et al. Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma. Ann Oncol 1999;10:235-7.